MoneyWorks4Me

Venus Remedies - Quaterly Results

31 Jan 2022 Evaluate
The quarter ended December 2021 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1174.42 millions.Profit saw a slight increase of 24.73%to Rs. 78.48  millions from Rs. 62.92 millions.Operating profit surged to 153.00 millions from the corresponding previous quarter of 141.91 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1174.42 1140.65 2.96 4469.33 4121.83 8.43 5146.23 3202.31 60.70
Other Income 10.72 11.53 -7.03 59.53 143.99 -58.66 177.62 35.79 396.28
PBIDT 153.00 141.91 7.81 674.77 533.96 26.37 646.25 466.47 38.54
Interest 0.00 17.32 0.00 0.00 118.59 -100.00 127.26 130.46 -2.45
PBDT 153.00 169.25 -9.60 674.77 444.27 51.88 753.41 247.89 203.93
Depreciation 84.00 84.24 -0.28 252.25 251.04 0.48 342.80 310.51 10.40
PBT 69.00 85.01 -18.83 422.52 193.23 118.66 410.61 -62.62 -755.72
TAX -9.48 22.09 -142.92 -43.14 36.99 -216.63 -132.12 19.64 -772.71
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 78.48 62.92 24.73 465.66 156.24 198.04 542.73 -82.26 -759.77
Equity 133.67 123.42 8.30 133.67 123.42 8.30 123.42 123.42 0.00
PBIDTM(%) 13.03 12.44 4.71 15.10 12.95 16.55 12.56 14.57 -13.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..